Remdesivir is an RNA polymerase inhibitor that is commonly used in the treatment of
patients with severe acute coronavirus disease 2019 (COVID-19). As the severe acute …

Remdesivir has seen extensive use during the coronavirus disease-2019 pandemic given
its clinically proven efficacy against severe acute respiratory syndrome coronavirus type 2 …

Remdesivir is an antiviral that inhibits RNA-dependent RNA polymerases of coronaviruses,
including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It is a …

Dear Editor: In the recent article by Mendez-Echevarria et al.[1], they shared their experience
with 8 pediatric patients with COVID-19 treated with Remdesivir in a safe and effective …

Background: Although remdesivir treatment is widely used during the pandemic coronavirus
disease 2019 (COVID-19), there is scarce evidence regarding its cardiac side effects. Case …

Remdesivir, a viral RNA–dependent RNA polymerase inhibitor, found extensive use in
coronavirus disease 2019–infected patients because it curbs the viral load expansion …

Food and Drug Administration for hospitalized patients≥ 12 years of age and weighing≥ 40
kg. It is also available through the Food and Drug Administration Emergency Use …

Recently, remdesivir was approved by the United States Food and Drug Administration for
patients with Coronavirus disease 2019 (COVID-19). We herein describe 3 patients with …

Background: Millions of children in the United States have been infected with severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), with many infections leading to …

Background: Remdesivir is widely used for the management of COVID-19 and several
studies have reported bradycardia as a potential side effect associated with this agent. The …